|
⚲
|
| Keyboard |
| Friedman Benzion Abraham
✚
|
|
|---|---|
| CIK # | 0001638415 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001638415] | |
| 4 | [0001638415] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cell Source Inc | |
| Friedman Benzion Abraham |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cell Source Inc CLCS
Common Stock
|
2021-06-30 | Other | 19,440 | $0.75 | 14,580 |
|
Cell Source Inc CLCS
Common Stock
|
2020-12-29 | Other | 19,672 | $0.75 | 14,754 |
|
Cell Source Inc CLCS
Director Stock Option (Right to Buy) · derivative
|
2020-08-20 | Disposed to issuer | 300,000 | $0.00 | |
|
Cell Source Inc CLCS
Director Stock Option (Right to Buy) · derivative
|
2020-08-20 | Grant | 300,000 | $0.00 | |
|
Cell Source Inc CLCS
Director Stock Option (Right to Buy) · derivative
|
2020-08-19 | Grant | 300,000 | $0.00 | |
|
Cell Source Inc CLCS
Common Stock
|
2020-06-30 | Other | 19,547 | $0.75 | 14,660 |
|
Cell Source Inc CLCS
Common Stock
|
2019-12-31 | Other | 25,675 | $0.75 | 19,256 |
|
Cell Source Inc CLCS
Common Stock
|
2019-06-26 | Other | 5,356 | $0.75 | 4,017 |
|
Cell Source Inc CLCS
Series A Convertible Preferred Stock · derivative
|
2019-05-07 | Grant | 31,553 | $7.50 | 236,648 |
|
Cell Source Inc CLCS
Common Stock
|
2018-12-31 | Other | 5,444 | $0.75 | 4,083 |
|
Cell Source Inc CLCS
Common Stock
|
2018-08-21 | Other | 6,672 | $0.75 | 5,004 |
|
Cell Source Inc CLCS
Common Stock
|
2017-12-04 | Other | 5,400 | $0.75 | 4,050 |
|
Cell Source Inc CLCS
Series A Convertible Preferred Stock · derivative
|
2017-07-26 | Grant | 12,000 | $15.00 | 180,000 |